WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics, today announced that the Company will report its financial results for the second quarter ended June 30, 2011 on Thursday, August 4, 2011, after the financial markets close. Following the release of the financial results, Allos management will provide a corporate update and review of the second quarter 2011 results via conference call and audio webcast. Access to the conference call and webcast may be obtained as follows:
